TKT and hepatocellular carcinoma: Next, western blotting showed oroxylin A dose‐dependently decreased TKT protein levels after 48 h treatment in Hep1‐6 mouse hepatoma cells (Figure 4A), whereas 14 days continuous treatment led to less TKT expression in HepG2 and SMMC‐7721 cells (Figure 4B).